ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.72
      -0.16%
      US Tech 100
      19,173.28
      -0.01%
      Dow Jones
      39,050.48
      -0.16%
      Brent Oil
      84.115
      -0.08%
      Bitcoin
      61,366.49
      -0.72%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Ascendis Pharma AS (ASND) Quote

      Ascendis Pharma AS

      Ascendis Pharma AS (ASND)

      ASN Duurzaam Aandelenfonds Inc
      Ascendant Resources Inc
      132.995
      -2.80
      ( -2.06% )
      Updated: 11:06:23
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      132.995
      Bid
      132.52
      Ask
      133.48
      Volume
      28,256
      131.60 Day's Range 135.79
      0.00 52 Week Range 0.00
      Market Cap
      -
      Previous Close
      135.79
      Open
      135.69
      Last Trade
      2
      @
      133
      Last Trade Time
      11:06:58
      Financial Volume
      $ 3,772,392
      VWAP
      133.5077
      Average Volume (3m)
      -
      Shares Outstanding
      56,614,385
      Dividend Yield
      -
      PE Ratio
      -
      Earnings Per Share (EPS)
      -
      Revenue
      -
      Net Profit
      -

      About Ascendis Pharma AS

      Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and ... Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.ascendispharma.com
      Headquarters
      Hellerup, Dnk
      Founded
      1970
      Ascendis Pharma AS is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ASND. The last closing price for Ascendis Pharma AS was $135.79. Over the last year, Ascendis Pharma AS shares have traded in a share price range of $ 0.00 to $ 0.00.

      Ascendis Pharma AS currently has 56,614,385 shares outstanding.

      ASND Latest News

      More News

      FeaturedPOET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program

      1 hour ago

      Data from Phase 2 ACcomplisH Trial of TransCon CNP in Children with Achondroplasia Presented at ICCHBH 2024

      • Data demonstrate significant improvements in well-being and physical functioning compared to placebo in patients treated for 1 year with TransCon CNP at the pivotal 100μg/kg/week dose •...

      June 24 2024
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      June 12 2024
      Edgar (US Regulatory)

      Ascendis Pharma to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

      COPENHAGEN, Denmark, June 04, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in a fireside chat at the Goldman Sachs 45th...

      June 04 2024
      GlobeNewswire Inc.

      Ascendis Pharma Presents New Data and Updated Results from Phase 1/2 IL-Believe Trial at ASCO 2024

      -  40% of efficacy-evaluable patients (2 out of 5) in the initial cohort of patients with anti-PD-1 refractory melanoma treated with TransCon IL-2 β/γ in combination with TransCon TLR7/8 Agonist...

      June 03 2024
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      May 31 2024
      Edgar (US Regulatory)

      Ascendis to Spotlight Latest Updates for TransCon™ Rare Endocrinology Disease Portfolio at ENDO 2024

      COPENHAGEN, Denmark, May 30, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that it will host informational booths, events, and presentations showcasing use of its...

      May 30 2024
      GlobeNewswire Inc.

      Form SD - Specialized disclosure report

      May 29 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      May 16 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      May 14 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DR
      40000000DR
      120000000DR
      260000000DR
      520000000DR
      1560000000DR
      2600000000DR

      Market Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      OPTXSyntec Optics Holdings Inc
      $ 7.94
      (237.87%)
      		22.77M
      WENAANEW MEDICAL INC
      $ 4.18
      (153.33%)
      		62.44M
      FFIEFaraday Future Intelligent Electric Inc
      $ 0.4909
      (85.25%)
      		400.23M
      CMAXCareMax Inc
      $ 2.79
      (46.84%)
      		288.85k
      AIEVThunder Power Holdings Inc
      $ 2.37
      (37.79%)
      		27.44M
      CNSPCNS Pharmaceuticals Inc
      $ 1.7006
      (-40.12%)
      		1.04M
      NUWENewellis Inc
      $ 0.132999
      (-38.94%)
      		7.57M
      GRIGRI Bio Inc
      $ 1.88
      (-36.70%)
      		510.92k
      LYELLyell Immunopharma Inc
      $ 1.395
      (-31.62%)
      		4.87M
      RELIReliance Global Group Inc
      $ 0.2737
      (-31.08%)
      		4.71M
      FFIEFaraday Future Intelligent Electric Inc
      $ 0.4909
      (85.25%)
      		400.23M
      NVDANVIDIA Corporation
      $ 123.43
      (-2.11%)
      		145.33M
      RIVNRivian Automotive Inc
      $ 15.56
      (30.10%)
      		143.4M
      WENAANEW MEDICAL INC
      $ 4.18
      (153.33%)
      		62.44M
      SQQQProShares UltraPro Short QQQ
      $ 8.2301
      (-1.91%)
      		41.73M

      ASND Discussion

      View Posts
      Monksdream Monksdream 4 months ago
      ASND new 52=week high
      👍️0
      Monksdream Monksdream 4 months ago
      ASND new 52 week high
      👍️0
      MiamiGent MiamiGent 4 months ago
      What goes down, must go up :)
      Hope you banked, monk.
      👍️0
      Monksdream Monksdream 4 months ago
      ASND new 52 week high
      👍️0
      Monksdream Monksdream 6 months ago
      ASND new 52 week high
      👍️0
      MiamiGent MiamiGent 1 year ago
      ASND 161 shares traded in pre-mkt. Take your profits- nobody going to hold up this dilution candidate.
      Bearish
      👍️0
      MiamiGent MiamiGent 1 year ago
      ASND After just one day of wooing, ASND is FALLING ...........in love with my short.
      Irresistible attraction: fourteen-month delay on average, need for more money and a red market with housing assuring further rate increase.
      Quote as of 5/02/2023 2:44PM ET
      $86.375 -$0.365 (-0.421%)
      Bearish
      https://www.bing.com/videos/search?q=you+tube+music+roy+orbison+i%27m+falling&view=detail&mid=17436B40AE02F042D00317436B40AE02F042D003&FORM=VIRE
      👍️0
      MiamiGent MiamiGent 1 year ago
      $ASND
      A complete response letter (CRL) from the FDA delays a product’s entry to the market by an average of 14 months. Companies that receive the letters take an average of seven months just to respond to them.
      FDA NEWS
      Bearish
      👍️0
      MiamiGent MiamiGent 1 year ago
      ASND Net Income -$622,419,000 in 2022

      Anyone want to venture a guess when the raise will come?

      I'll take a WAG and say within two weeks.
      👍️0
      MiamiGent MiamiGent 1 year ago
      ASND Quote as of 5/02/2023 10:14AM ET

      $88.07 +$1.33 (+1.533%)

      I'm down -3.22% on my short. Did not choose well- 100% owned by institutions.. not easily budged.
      I am counting on red days, 3 day rule, CRL and outside chance of a raise- it's all I got, lol

      https://stockcharts.com/h-sc/ui?s=ASND
      👍️0
      MiamiGent MiamiGent 1 year ago
      Short today at 85.34

      How long will this languish before possible good news?

      Will need to raise more $$
      👍️0
      crudeoil24 crudeoil24 3 years ago
      Ascendis Pharma: FDA Approves Skytrofa to Treat Pediatric Growth Hormone Deficiency > ASND
      3:46 pm ET August 25, 2021

      By Stephen Nakrosis

      Ascendis Pharma A/S on Wednesday said the U.S. Food and Drug Administration approved its Skytrofa as a treatment for Pediatric Growth Hormone Deficiency.

      The company said Skytrofa, or lonapegsomatropin-tcgd, is the first once-weekly treatment approved to treat Pediatric Growth Hormone Deficiency.

      The company also said Skytrofa was approved to treat "pediatric patients one year and older who weigh at least 11.5 kg and have growth failure due to inadequate secretion of endogenous growth hormone."

      The company said the approval includes its Skytrofa Auto-Injector and cartridges, which enable families to store the medicine at room temperature for up to six months.

      The company said availability of Skytrofa in the U.S. is expected soon.

      Ascendis said it would hold an investor conference call at 4:30 p.m. ET today.


      Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
      👍️0
      crudeoil24 crudeoil24 3 years ago

      ASCENDIS PHARMA A/S is a Danish-based biopharmaceutical company, which is involved in manufacture products for rare diseases. The Company utilizes its TransCon technologies for treatment, which can be applied to existing drug therapies, including proteins, peptides and small molecules, to create prodrugs. The Company is headquartered in Copenhagen, Denmark with offices in Heidelberg, Germany and Palo Alto, California.
      👍️0

      Your Recent History

      NASDAQ
      ASND
      Ascendis Pharma AS
      USOTC
      CCEDF
      Cascadero Copper (PK)
      Delayed Upgrade Clock